These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21171826)

  • 1. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
    Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR
    Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
    Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
    Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool?
    Rizzo R; Melchiorri L; Simone L; Stignani M; Marzola A; Gullini S; Baricordi OR
    Inflamm Bowel Dis; 2008 Jan; 14(1):100-5. PubMed ID: 17886287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
    Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
    Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
    Ozerol I; Ageitos A; Heimann DG; Talmadge JE
    Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased production of human leukocyte antigen G molecules in sinonasal polyposis.
    Malagutti N; Aimoni C; Balboni A; Stignani M; Melchiorri L; Borin M; Pastore A; Rizzo R; Baricordi OR
    Am J Rhinol; 2008; 22(5):468-73. PubMed ID: 18954504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
    Trivedi P; Hematti P
    Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
    Kuçi Z; Kuçi S; Zircher S; Koller S; Schubert R; Bönig H; Henschler R; Lieberz R; Klingebiel T; Bader P
    Cytotherapy; 2011 Nov; 13(10):1193-204. PubMed ID: 21905954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
    Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
    Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
    Lin W; Oh SK; Choo AB; George AJ
    Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs.
    Campioni D; Rizzo R; Stignani M; Melchiorri L; Ferrari L; Moretti S; Russo A; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Cuneo A; Baricordi OR; Lanza F
    Cytometry B Clin Cytom; 2009 May; 76(3):225-30. PubMed ID: 18985728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G.
    Du WJ; Reppel L; Leger L; Schenowitz C; Huselstein C; Bensoussan D; Carosella ED; Han ZC; Rouas-Freiss N
    Stem Cells Dev; 2016 Oct; 25(19):1454-69. PubMed ID: 27465875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.